Alyeska Investment Group
TECH icon

Alyeska Investment Group’s Bio-Techne TECH Stock Holding History

Alyeska Investment Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Sell
3,691
-655,358
-99% -$35.4M ﹤0.01% 642
2026
Q1 		$34.4M Buy
+659,049
New +$39.6M 0.1% 237
2024
Q2 		– Sell
-911,526
Closed -$64.2M – 670
2024
Q1 		$64.2M Buy
911,526
+6,704
+0.7% +$480K 0.39% 84
2023
Q4 		$69.8M Buy
904,822
+194,253
+27% +$12.8M 0.46% 70
2023
Q3 		$48.4M Sell
710,569
-379,218
-35% -$30M 0.33% 104
2023
Q2 		$89M Buy
+1,089,787
New +$87.6M 0.66% 31
2020
Q4 		– Sell
-361,212
Closed -$22.4M – 601
2020
Q3 		$22.4M Buy
361,212
+29,020
+9% +$1.89M 0.34% 89
2020
Q2 		$21.9M Buy
332,192
+76,992
+30% +$4.61M 0.33% 107
2020
Q1 		$12.1M Buy
255,200
+243,680
+2,115% +$12.2M 0.24% 114
2019
Q4 		$632K Buy
+11,520
New +$604K 0.01% 344
2019
Q2 		– Sell
-24,436
Closed -$1.21M – 516
2019
Q1 		$1.21M Buy
+24,436
New +$1.1M 0.02% 308

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alyeska Investment Group's TECH Position: Q2 2026 in Review

Alyeska Investment Group reduced its Bio-Techne (TECH) stake by 99% in Q2 2026, selling an estimated $35.4M and leaving 3,691 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Alyeska Investment Group first reported a position in TECH in Q1 2019 and has held it in 11 quarters since. The position peaked at $89M in Q2 2023. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Alyeska Investment Group held 3,691 shares of Bio-Techne worth $261K as of Q2 2026.
  • Alyeska Investment Group sold 655,358 Bio-Techne shares in Q2 2026, an estimated $35.4M.
  • Bio-Techne made up ﹤0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #642 holding.
  • Alyeska Investment Group first reported a position in Bio-Techne in Q1 2019 and has held it in 11 quarters since.
  • Alyeska Investment Group's Bio-Techne position peaked at $89M in Q2 2023.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.